Foley Partner Antoinette Konski authored an article that appeared in the September 2011 issue of BioProcess International titled “Generic Biologics.” Konski reviews several key provisions of various regulatory pathways for generic biologics in the United States, China, India and throughout Europe, and discusses how these pathways could support biosimilar manufacturing.
Click here to read the complete article.
Autor(es)
Información relacionada
December 8, 2025
Foley Viewpoints
2026 Outlook: AI, IPOs, and the New “Normal” in Venture & Private Equity
Key Takeaways The 2026 outlook for market activity is cautiously optimistic amid ongoing challenges.Private equity firms are shifting to…
December 8, 2025
Labor & Employment Law Perspectives
Colorado Adds New NICU Leave Under FAMLI: What Employers Should Know
Colorado’s Family and Medical Leave Insurance (FAMLI) program has provided employees with paid leave for major life events since 2024,…
December 8, 2025
Labor & Employment Law Perspectives
The Post-Shutdown Compliance Crunch: Preparing for Agency Action
The longest federal government shutdown in U.S. history has ended, and employers must now refocus their attention on agency actions and…